March 17th 2023
The findings have potential clinical and public health implications and highlight the greater role of metabolic health status than obesity in IOP elevation, according to the authors.
Japanese investigators identify gene required for survival of retinal ganglion cells
March 27th 2022A team of investigators at the Okinawa Institute of Science and Technology Graduate University in Japan have identified a gene necessary for the survival of retinal ganglion cells—a class of neurons located in the retina that are critical for vision.
Pilot project aims to overcome inequalities in glaucoma diagnoses
March 10th 2022Many low- and middle-income countries lack resources for managing eye health. A pilot project aims to reduce the number of people going blind from untreated glaucoma by raising awareness and increasing engagement with screening and follow-up.
Heidelberg Engineering becomes member of Glaucoma/Myopia OCT Phenotyping Consortium
February 5th 2022The GMOPC was established in February 2020 at an inaugural meeting in Los Angeles, California, as an investigator-initiated clinical research study, with Heidelberg Engineering as an industry partner.
Study of bimatoprost implant reports IOP reduction for 2 years or more
November 12th 2021Dr Felipe Medeiros in a presentation at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, noted that a phase 3 clinical extension study of the bimatoprost implant found that patients’ IOP was lowered and stayed low with no additional treatment or changes in their visual fields.